Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 1
2007 3
2008 2
2011 1
2012 3
2013 2
2014 2
2015 3
2018 3
2019 5
2020 6
2021 6
2022 4
2023 7
2024 10
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, Anstee QM, Hussain SA, Newsome PN, Ratziu V, Hosseini-Tabatabaei A, Schattenberg JM, Noureddin M, Alkhouri N, Younes R; 1404-0043 Trial Investigators. Sanyal AJ, et al. N Engl J Med. 2024 Jul 25;391(4):311-319. doi: 10.1056/NEJMoa2401755. Epub 2024 Jun 7. N Engl J Med. 2024. PMID: 38847460 Clinical Trial.
Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices.
Brzdęk M, Zarębska-Michaluk D, Kukla M, Janocha-Litwin J, Dybowska D, Janczewska E, Lorenc B, Berak H, Mazur W, Tudrujek-Zdunek M, Klapaczyński J, Piekarska A, Sitko M, Laurans Ł, Parfieniuk-Kowerda A, Flisiak R. Brzdęk M, et al. Among authors: dybowska d. Pharmacol Rep. 2024 Oct;76(5):1114-1129. doi: 10.1007/s43440-024-00639-9. Epub 2024 Aug 20. Pharmacol Rep. 2024. PMID: 39162985 Free PMC article.
Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens.
Tronina O, Brzdęk M, Zarębska-Michaluk D, Dybowska D, Lorenc B, Janczewska E, Mazur W, Parfieniuk-Kowerda A, Piekarska A, Krygier R, Klapaczyński J, Berak H, Jaroszewicz J, Garlicki A, Tomasiewicz K, Citko J, Flisiak R. Tronina O, et al. Among authors: dybowska d. Viruses. 2023 Mar 4;15(3):677. doi: 10.3390/v15030677. Viruses. 2023. PMID: 36992388 Free PMC article.
Direct-acting antivirals in women of reproductive age infected with hepatitis C virus.
Dobrowolska K, Pawłowska M, Zarębska-Michaluk D, Rzymski P, Janczewska E, Tudrujek-Zdunek M, Berak H, Mazur W, Klapaczyński J, Lorenc B, Janocha-Litwin J, Parfieniuk-Kowerda A, Dybowska D, Piekarska A, Krygier R, Dobracka B, Jaroszewicz J, Flisiak R. Dobrowolska K, et al. Among authors: dybowska d. J Viral Hepat. 2024 Jun;31(6):309-319. doi: 10.1111/jvh.13936. Epub 2024 Mar 14. J Viral Hepat. 2024. PMID: 38483035
HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.
Rajewski P, Zarębska-Michaluk D, Janczewska E, Gietka A, Mazur W, Tudrujek-Zdunek M, Tomasiewicz K, Belica-Wdowik T, Baka-Ćwierz B, Dybowska D, Halota W, Lorenc B, Sitko M, Garlicki A, Berak H, Horban A, Orłowska I, Simon K, Socha Ł, Wawrzynowicz-Syczewska M, Jaroszewicz J, Deroń Z, Czauż-Andrzejuk A, Citko J, Krygier R, Piekarska A, Laurans Ł, Dobracki W, Białkowska J, Tronina O, Wietlicka-Piszcz M, Pawłowska M, Flisiak R. Rajewski P, et al. Among authors: dybowska d. J Clin Med. 2022 Jan 13;11(2):379. doi: 10.3390/jcm11020379. J Clin Med. 2022. PMID: 35054072 Free PMC article.
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.
Piekarska A, Berkan-Kawińska A, Berak H, Mazur W, Sitko M, Parfieniuk-Kowerda A, Lorenc B, Dybowska D, Janczewska E, Janocha-Litwin J, Dobracka B, Socha Ł, Tudrujek-Zdunek M, Flisiak R. Piekarska A, et al. Among authors: dybowska d. Expert Rev Anti Infect Ther. 2024 Sep;22(9):775-780. doi: 10.1080/14787210.2024.2353691. Epub 2024 May 16. Expert Rev Anti Infect Ther. 2024. PMID: 38722307
Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people.
Brzdęk M, Zarębska-Michaluk D, Tomasiewicz K, Tudrujek-Zdunek M, Lorenc B, Mazur W, Berak H, Janocha-Litwin J, Klapaczyński J, Sitko M, Janczewska E, Dybowska D, Parfieniuk-Kowerda A, Piekarska A, Jaroszewicz J, Flisiak R. Brzdęk M, et al. Among authors: dybowska d. Minerva Med. 2024 Jun;115(3):266-276. doi: 10.23736/S0026-4806.24.09238-3. Epub 2024 Apr 9. Minerva Med. 2024. PMID: 38591836
Effectiveness of pangenotypic retreatment of chronic hepatitis C after prior failure of pangenotypic therapies.
Jaroszewicz J, Zarębska-Michaluk D, Janocha-Litwin J, Parfieniuk-Kowerda A, Sitko M, Piekarska A, Białkowska J, Dybowska D, Murawska-Ochab A, Flisiak R. Jaroszewicz J, et al. Among authors: dybowska d. Pol Arch Intern Med. 2023 Mar 29;133(3):16400. doi: 10.20452/pamw.16400. Epub 2023 Jan 5. Pol Arch Intern Med. 2023. PMID: 36602060 Free article.
Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure.
Tronina O, Brzdęk M, Zarębska-Michaluk D, Lorenc B, Janocha-Litwin J, Berak H, Sitko M, Dybowska D, Mazur W, Tudrujek-Zdunek M, Janczewska E, Klapaczyński J, Dobracki W, Parfieniuk-Kowerda A, Krygier R, Socha Ł, Flisiak R. Tronina O, et al. Among authors: dybowska d. Clin Exp Hepatol. 2023 Dec;9(4):320-334. doi: 10.5114/ceh.2023.133307. Epub 2023 Dec 15. Clin Exp Hepatol. 2023. PMID: 38774196 Free PMC article.
56 results